Overview
In September 2010 an Erasmus Mundus Master’s course, called CEMACUBE (Common European MAster’s CoUrse in Biomedical Engineering) will start. The goal of this course is to prepare students from Europe and outside Europe for professions in Biomedical Engineering.
For a single university it is difficult to have enough knowledge of all sub-specialisations in Biomedical Engineering to teach their students on an adequate level. Also the required European scope is difficult to gain when students stick to a single university. Therefore a consortium of 6 universities has joined their knowledge and specific expertise into a 2-year European Master’s in Biomedical Engineering.
During the first year (semester 1 and 2), students will follow lectures on all biomedical engineering subjects at one of the six universities, after which the student will move to one of the other participating universities to follow lectures on a specific topic during the 3rd semester, such as medical imaging, tissue engineering or artificial organs. In the fourth and last semester, a Master’s project will be performed in the area of this specialisation.
Participating universties
The participating universities are the University of Groningen (The Netherlands), Aachen (Germany), Dublin (Ireland), Ghent and Brussels (Belgium) and Prague (Czech Republic). Each student studying in the CEMACUBE program will receive a double degree. Admission criteria are: a Bachelor in engineering and good knowledge of English (all teaching will be given in English), a convincing motivation letter and letters of reference.
Students that followed this European Master’s course in Biomedical Engineering are trained with a Europan view, experienced in intercultural and interdisciplinary teamwork. They will have a broad overview of the entire field of BME.
Erasmus Mundus
Erasmus Mundus Masters are funded by the European Union. Together with 18 other Master programmes, CEMACUBE has in 2009 been selected as a new Erasmus Mundus Master programme that will be funded for five years (with possible extension of another 5 years). The competition was fierce; only about 20% of the proposals for new Erasmus Mundus Masters have been awarded funding.
Erasmus Mundus aims to enhance the quality of higher education in Europe, and to promote dialogue and understanding between people and cultures through cooperation with third-world countries. In addition, it contributes to the development of human resources and the international cooperation capacity of higher education institutions in non-European countries by increasing mobility between the European Union and these countries. CEMACUBE falls under ‘Action 1’ of Erasmus Mundus; joint programmes of outstanding quality at masters and doctoral levels including scholarships/fellowships to participate in these programmes.
For more information about CEMACUBE, please visit www.biomedicaltechnology.eu
If you have any questions, contact Piet van den Berg (Pieter.van.den.berg AT rug.nl)
Please kindly mention Scholarization.blogspot.com when applying for this opportunity
In September 2010 an Erasmus Mundus Master’s course, called CEMACUBE (Common European MAster’s CoUrse in Biomedical Engineering) will start. The goal of this course is to prepare students from Europe and outside Europe for professions in Biomedical Engineering.
For a single university it is difficult to have enough knowledge of all sub-specialisations in Biomedical Engineering to teach their students on an adequate level. Also the required European scope is difficult to gain when students stick to a single university. Therefore a consortium of 6 universities has joined their knowledge and specific expertise into a 2-year European Master’s in Biomedical Engineering.
During the first year (semester 1 and 2), students will follow lectures on all biomedical engineering subjects at one of the six universities, after which the student will move to one of the other participating universities to follow lectures on a specific topic during the 3rd semester, such as medical imaging, tissue engineering or artificial organs. In the fourth and last semester, a Master’s project will be performed in the area of this specialisation.
Participating universties
The participating universities are the University of Groningen (The Netherlands), Aachen (Germany), Dublin (Ireland), Ghent and Brussels (Belgium) and Prague (Czech Republic). Each student studying in the CEMACUBE program will receive a double degree. Admission criteria are: a Bachelor in engineering and good knowledge of English (all teaching will be given in English), a convincing motivation letter and letters of reference.
Students that followed this European Master’s course in Biomedical Engineering are trained with a Europan view, experienced in intercultural and interdisciplinary teamwork. They will have a broad overview of the entire field of BME.
Erasmus Mundus
Erasmus Mundus Masters are funded by the European Union. Together with 18 other Master programmes, CEMACUBE has in 2009 been selected as a new Erasmus Mundus Master programme that will be funded for five years (with possible extension of another 5 years). The competition was fierce; only about 20% of the proposals for new Erasmus Mundus Masters have been awarded funding.
Erasmus Mundus aims to enhance the quality of higher education in Europe, and to promote dialogue and understanding between people and cultures through cooperation with third-world countries. In addition, it contributes to the development of human resources and the international cooperation capacity of higher education institutions in non-European countries by increasing mobility between the European Union and these countries. CEMACUBE falls under ‘Action 1’ of Erasmus Mundus; joint programmes of outstanding quality at masters and doctoral levels including scholarships/fellowships to participate in these programmes.
For more information about CEMACUBE, please visit www.biomedicaltechnology.eu
If you have any questions, contact Piet van den Berg (Pieter.van.den.berg AT rug.nl)
Please kindly mention Scholarization.blogspot.com when applying for this opportunity
0 comments:
Post a Comment